Microchip Technology Incorporated · Technology
Paid for today, but breaks on a small cut — or only looks over-priced at a 9% discount rate.
At a 25.0% margin the price needs +15.2% 3y revenue CAGR against +21.2% consensus, a cushion of -2.9pt versus a 2.0pt correction cut. Under a 3pt flush it is fragile. Weak channel; recovery cycle matters more.
Would recover if: Wrong if the 2.0pt cut is too harsh (growth holds near 21%) and margin holds at 25%+; worse if margin settles below 25%, which turns the -2.9pt cushion negative.. We re-check this against analyst estimates every evening.
10 years, at a 25% margin analysts expect
+13.5%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
15 published targets, set before the drop
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 194% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 4, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price at the price sits at the absolute bottom of 15 published models (0th percentile by count), 38% below the median target of $117, meaning the market completely rejects the analyst consensus and prices no chance of the growth acceleration those models require.
Can Microchip's revenue growth actually accelerate from the current 7.1% toward the 18% the price requires, and the wired data can track this via unit volumes but cannot measure the pricing power needed to expand margins.
What the price refuses to pay for, and the full reconstruction, on the MCHP quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names